1. Introduction

Bioprospecting licensing and enforcement in Australia concerns the legal rules governing the collection, access, research, development and commercial use of biological resources and associated traditional knowledge. These resources may include plants, animals, microorganisms, genetic material and biochemical compounds that have potential pharmaceutical, agricultural, industrial or biotechnological applications.

Bioprospecting may lead to the discovery of medicines, enzymes, cosmetics, crop varieties or other commercially valuable products. However, it also raises legal questions about biodiversity conservation, ownership of biological materials, Indigenous rights, benefit-sharing, research permits and the prevention of unauthorised commercial exploitation.

Australia's regulatory system is not governed by a single, comprehensive bioprospecting statute. Instead, it involves a combination of:

The Environment Protection and Biodiversity Conservation Act 1999 (Cth) (EPBC Act).

The Environment Protection and Biodiversity Conservation Regulations 2000, including access and benefit-sharing requirements.

State and territory biodiversity, parks, wildlife and land-access laws.

Commonwealth and state rules governing Indigenous cultural heritage and traditional knowledge.

Intellectual property, contract, biosecurity and export-control laws where applicable.

A central distinction is that permission to collect a biological resource does not necessarily confer permission to commercialise it, patent a resulting invention, export it or use associated Indigenous knowledge. Each activity may trigger different legal requirements.

2. Principal legislation and regulatory framework

A. Commonwealth law

The primary federal framework is the EPBC Act and the current Environment Protection and Biodiversity Conservation Regulations 2025. The regulations replaced the 2000 regulations from 19 December 2025, so current applications should be assessed under the new instrument rather than relying exclusively on older guidance.

DCCEEW+2

Under Part 8A of the 2025 Regulations, the access-and-benefit-sharing framework applies to covered biological resources in defined Commonwealth areas.

Important provisions include:

These provisions must be read together with the rest of the Regulations, including the permit-application provisions.

Federal Register of Legislation

Territorial limitation: The Commonwealth framework does not automatically regulate every biological resource collected anywhere in Australia. State and territory law, the location of the resource, the legal status of the land or waters, and the nature of the proposed activity determine which additional approvals are required.

B. Queensland: Biodiscovery Act 2004

Queensland has a particularly developed statutory framework under the Biodiscovery Act 2004.

Its principal objectives are to:

Facilitate sustainable collection and use of native biological material.

Ensure fair and equitable sharing of benefits with the State.

Protect Indigenous traditional knowledge used in biodiscovery.

Encourage research and value-added biotechnology in Queensland.

Monitor and enforce compliance with collection and use conditions.

For covered biodiscovery on State land or in Queensland waters, an applicant generally needs a collection authority (biodiscovery) and a benefit-sharing agreement with the State before commencing the regulated activity. The collection authority is subject to conditions and a compliance code.

Queensland Government+2

C. Northern Territory and Australian Capital Territory

Other jurisdictions have their own rules. The Northern Territory's Biological Resources Act 2006 establishes a resource-access and benefit-sharing framework, while the ACT's Nature Conservation Act 2014 addresses relevant access to biological resources in reserves for commercial purposes. The precise application of each law depends on the resource and collection location.

Australia state of the environment 2021

Consequently, a company operating nationally may need a different permit, agreement or compliance process for each jurisdiction in which it obtains biological material.

3. What activities constitute bioprospecting?

Bioprospecting usually involves systematically investigating biological material for useful genetic, biochemical or biological properties.

1. Collection and sampling

Collecting native plants, fungi, microorganisms or animal material from a covered area. Collection may require a permit even before any commercially useful compound has been discovered.

2. Genetic and biochemical research

Analysing DNA, proteins, enzymes, metabolites or other compounds to identify possible scientific or commercial applications.

3. Product development and commercialisation

Developing a drug candidate, agricultural product, enzyme, diagnostic technology or cosmetic ingredient from the research.

4. Transfer, export and downstream use

Sending samples to another institution, transferring them to a commercial partner, sequencing genetic material, or licensing a resulting technology. These activities may trigger contractual restrictions or separate legal controls.

The Commonwealth definition is particularly important because it covers access where there is a reasonable prospect that the collected biological resources will be subject to research and development on their genetic resources or biochemical compounds. Merely labelling a project “academic” or “exploratory” does not necessarily remove it from the rules.

Federal Register of Legislation

4. Licensing procedure in Australia

The precise procedure varies by jurisdiction, but a prudent licensing process follows these stages.

Stage 1 — Identify the resource and jurisdiction

Determine the species, sample type, proposed collection site, landowner or access provider, and whether the resource falls within a Commonwealth area, State land, a protected area or Indigenous-held land.

Stage 2 — Determine the permits required

Establish whether a bioprospecting permit, collection authority, protected-area permit, wildlife approval or other authorisation is necessary.

Stage 3 — Obtain consent and negotiate benefit sharing

Identify the legally relevant access providers and, where traditional knowledge is involved, its custodians. Agree on the authorised purpose, permitted use, confidentiality, benefits, intellectual property arrangements and any restrictions on transfer.

Stage 4 — Obtain formal approval

Submit the prescribed application, required agreements and supporting evidence. Do not assume that negotiating an agreement alone authorises collection.

Stage 5 — Comply throughout the research lifecycle

Maintain sample records, comply with quantity and location limits, report as required, observe transfer restrictions, and renegotiate or obtain approval if the proposed use changes.

For Commonwealth areas, the Department of Climate Change, Energy, the Environment and Water provides official information about biological-resource permits and benefit-sharing agreements.

DCCEEW+1

For Queensland, the official biodiscovery licensing guidance explains collection authorities and related obligations.

5. Benefit-sharing agreements

Benefit sharing is one of the central legal mechanisms in Australia's bioprospecting framework. It seeks to ensure that the economic and other advantages arising from biological resources are not obtained without complying with the relevant access rules and agreed obligations.

A. Forms of benefits

A benefit-sharing agreement may provide for:

Monetary benefits: upfront payments, milestone payments, royalties or a share of commercial revenue.

Research benefits: joint research, access to results, laboratory facilities and scientific training.

Conservation benefits: funding for habitat protection, species monitoring or ecological restoration.

Community benefits: education, employment, capacity building or other agreed social benefits.

Knowledge-related benefits: recognition, confidentiality, attribution and agreed terms for the use of Indigenous knowledge.

The precise benefits depend on the applicable legislation and negotiated agreement; there is no universal royalty percentage applicable to every Australian bioprospecting project.

B. Essential contractual terms

A well-drafted agreement should address:

Under the Commonwealth framework, regulation 8A.08 expressly addresses several of these matters, including the purpose of access, the agreed disposition of sample ownership, Indigenous knowledge and the benefits to be received by the access provider.

Federal Register of Legislation+1

C. Indigenous traditional knowledge

Traditional knowledge may include knowledge of medicinal plants, healing practices, food sources, ecological indicators and the useful properties of native organisms.

A researcher who lawfully obtains a plant sample does not thereby acquire unrestricted rights to exploit the community's knowledge about that plant.

Queensland's 2020 reforms introduced a statutory traditional-knowledge obligation, supported by the Traditional Knowledge Code of Practice 2021. The framework requires relevant biodiscovery entities to take appropriate steps to identify knowledge custodians and ensure that traditional knowledge is used under an agreement with those custodians.

Environment Queensland+1

Under the Commonwealth regulations, relevant commercial access agreements must address the protection, recognition and valuation of Indigenous knowledge. Regulation 8A.10 also establishes informed-consent safeguards in the circumstances it specifies.

Federal Register of Legislation

The legal and ethical principle is that physical access to a biological resource, legal rights in the land, and authority to use traditional knowledge are distinct matters.

6. Enforcement mechanisms and legal consequences

Enforcement can arise through administrative action, statutory penalties, contractual proceedings, environmental law and intellectual property disputes.

A. Regulatory enforcement

Authorities may examine whether the collector or research organisation has:

Obtained the required permit or collection authority.

Complied with location, species, quantity and collection conditions.

Entered into required benefit-sharing agreements.

Obtained the relevant permissions before using traditional knowledge.

Complied with restrictions on sample transfer and subsequent commercial research.

Submitted required records and reports.

In Commonwealth areas, regulation 8A.06 provides for a penalty of 50 penalty units for covered access without the required permit. Other consequences depend on the particular offence, permit conditions and legislation involved.

Federal Register of Legislation

The Commonwealth environmental framework also provides compliance and enforcement mechanisms for contraventions involving protected environmental matters. Whether those mechanisms apply to a particular bioprospecting operation depends on the activity and the statutory provisions engaged.

DCCEEW

B. Contractual enforcement

A benefit-sharing agreement can establish obligations that are enforceable according to its terms and applicable law. Depending on the facts, potential remedies may include:

An injunction to prevent unauthorised use or disclosure.

Damages for breach of contract or breach of confidence.

Termination or suspension of contractual rights.

Recovery of unpaid agreed benefits.

Dispute-resolution proceedings, including arbitration where validly agreed.

A contractual breach does not automatically constitute a criminal offence. Conversely, a permit holder may breach statutory conditions even if no contractual dispute has arisen.

C. Intellectual property enforcement

Australian patent law may protect qualifying inventions derived from bioprospecting, but a patent is not itself a licence to collect or use biological material.

A patent application must satisfy applicable requirements such as novelty, inventive step and the other conditions of the Patents Act 1990 (Cth). An existing patent also does not necessarily establish ownership of the underlying biological resource or extinguish obligations under a benefit-sharing agreement.

The distinction matters because three separate questions can arise:

Was the biological resource lawfully accessed?

Is the resulting invention patentable and who owns it?

Has the resulting product been commercialised consistently with permits, agreements and other applicable laws?

A favourable answer to one question does not automatically resolve the others.

D. International transfers and cross-border enforcement

Where biological material or genetic information is transferred internationally, the parties should assess applicable Australian export requirements, biosecurity controls, contractual transfer restrictions and any relevant foreign access-and-benefit-sharing rules.

The Nagoya Protocol is an international instrument concerning access to genetic resources and fair and equitable benefit sharing. It does not mean that every international transfer of Australian biological material is automatically prohibited or that the same rules apply to all material. The relevant domestic implementing law, source of the resource, intended use and applicable international obligations must be examined.

7. Important Australian case laws

There is an important qualification: the cases below provide principles relevant to biological-resource access, Indigenous rights, confidentiality and commercial exploitation. They should not be misrepresented as judgments directly interpreting the current bioprospecting permit provisions.

1. Yanner v Eaton, [1999] HCA 53; (1999) 201 CLR 351

High Court of Australia

Facts: Marandoo Yanner, a member of the Gangalidda people, took crocodiles in the exercise of traditional practices without a licence under Queensland fauna legislation. The legislation also declared fauna to be the property of the Crown.

Legal issue: Whether the statutory declaration of Crown ownership and licensing restrictions extinguished the relevant native title right.

Decision: The High Court held that the relevant traditional hunting right had not been extinguished by the legislation. The judgment explained that the statutory vesting of fauna in the Crown did not necessarily amount to full beneficial ownership.

Relevance to bioprospecting: The case cautions against treating a general statutory declaration of Crown ownership as resolving every question about traditional rights to biological resources. It supports careful analysis of the relationship between statutory licensing, resource control and native title.

It does not, however, establish a general Indigenous veto over every bioprospecting activity or decide the requirements of the current Commonwealth benefit-sharing framework.

Source: High Court of Australia — Yanner v Eaton.

High Court of Australia+1

2. Foster v Mountford, (1976) 29 FLR 233; (1977) 14 ALR 71

Facts: Anthropologist C. P. Mountford had gathered culturally sensitive information from Aboriginal people. Its subsequent publication threatened to disclose knowledge that the community had communicated in confidence.

Legal issue: Whether the information could be protected through the common-law doctrine of breach of confidence.

Decision: The court granted injunctive relief restraining publication of the confidential material.

Relevance to bioprospecting: The case demonstrates that traditional knowledge can receive legal protection through confidentiality principles, even where conventional intellectual property protection is unavailable or inadequate.

For example, a researcher who receives confidential information about a medicinal plant may face legal restrictions on disclosure or use if the elements of breach of confidence are established.

However, the case does not establish automatic ownership of every item of traditional knowledge or create a universal statutory benefit-sharing right.

Source: Australian Institute of Aboriginal and Torres Strait Islander Studies — National Bench Book.

nbb.aija.org.au+1

3. Akiba on behalf of the Torres Strait Regional Seas Claim Group v Commonwealth, [2013] HCA 33; (2013) 250 CLR 209

Facts: The proceedings concerned native title rights in marine areas of the Torres Strait, including the right to take resources for various purposes.

Legal issue: Whether the relevant native title rights were extinguished or restricted by fisheries legislation, particularly in relation to taking resources for trade.

Decision: The High Court recognised the relevant native title right to take resources for any purpose, including trade, subject to the scope of the determination and applicable regulation.

Relevance to bioprospecting: The case illustrates why traditional rights relating to biological resources must be assessed individually. Rights to access or take resources may have legal significance even where government licensing and conservation regulation also apply.

It does not mean that a native title right automatically authorises commercial genetic research, removes permit requirements or supplies consent for the use of traditional knowledge.

Source: High Court of Australia — judgment materials.

High Court of Australia+1

4. Bulun Bulun v R & T Textiles Pty Ltd, [1998] FCA 1082

Facts and legal issue: The dispute concerned the reproduction of an Aboriginal artist's work and raised questions about copyright ownership and the interests of the artist's community in culturally significant material.

Legal significance: The case is important in considering the relationship between individual intellectual property rights and Indigenous communal cultural interests.

Relevance to bioprospecting: Where a bioprospecting project uses Indigenous illustrations, written materials, research publications or other copyright-protected works, conventional intellectual property law may provide some protection. But copyright in a document or artwork is different from ownership of a plant, genetic sequence or underlying traditional knowledge.

The case therefore illustrates a limitation of relying exclusively on intellectual property law to protect Indigenous interests in biological-resource research.

Source: World Intellectual Property Organization — materials on Indigenous traditional knowledge.

WIPO+1

5. Mabo v Queensland (No 2), [1992] HCA 23; (1992) 175 CLR 1

Facts and legal issue: The case concerned recognition of native title under Australian common law and the effect of traditional laws and customs on land rights.

Decision: The High Court recognised native title as a form of common-law interest arising from the traditional laws and customs of Indigenous peoples, subject to the principles governing recognition and extinguishment.

Relevance to bioprospecting: The decision provides foundational context for assessing access to biological resources located on land over which native title rights exist. It helps explain why legal access to a site and authority to collect resources cannot always be determined solely by reference to Crown land classifications.

The case did not establish a comprehensive statutory system of genetic-resource ownership or benefit sharing.

Source: High Court of Australia — case and judgment resources. See also the legal discussion of native title and resource rights in Yanner v Eaton.

High Court of Australia+1

Case-law comparison

8. International law and Australia's benefit-sharing approach

Three international instruments are particularly relevant.

Convention on Biological Diversity (CBD), 1992

The CBD recognises State sovereignty over natural resources and establishes a framework for biodiversity conservation, sustainable use and fair benefit sharing from genetic resources.

Nagoya Protocol, 2010

The Protocol develops international rules on access to genetic resources, prior informed consent where applicable, mutually agreed terms and benefit sharing. Its application depends on the relevant parties, resources, domestic implementing measures and applicable exceptions.

International Treaty on Plant Genetic Resources for Food and Agriculture

This treaty establishes a specialised multilateral system for specified plant genetic resources used for food and agriculture. Certain Queensland biodiscovery activities involving Annex I plants may fall within an applicable statutory exemption when the treaty's conditions are satisfied.

Environment Queensland+1

These instruments do not replace Australia's domestic licensing requirements. They provide the broader context in which national access and benefit-sharing arrangements operate.

9. Hypothetical enforcement scenario

Consider a pharmaceutical company that collects a native Australian plant from covered Commonwealth land, analyses its biochemical compounds, and discovers a potentially valuable drug candidate.

The company then sends the samples to an overseas laboratory and licenses the resulting technology to another business.

Several legal questions arise:

Question 1: Was collection authorised?

The company must establish whether the resource and location are covered by Part 8A and whether the necessary permit was in force. An agreement alone may not be sufficient.

Question 2: Were benefit-sharing obligations met?

If the access was for commercial or potentially commercial purposes, the company must satisfy the applicable agreement and informed-consent requirements. Any use of Indigenous knowledge must also be addressed where the relevant provisions apply.

Question 3: Was overseas transfer authorised?

The company must check the permit, benefit-sharing agreement, transfer restrictions and any other applicable export or biosecurity rules. Permission to collect does not necessarily permit unrestricted onward transfer.

Question 4: What enforcement action is available?

Depending on the breach, the matter may lead to regulatory investigation, statutory penalties, contractual claims, an injunction or other applicable proceedings. The remedy depends on the actual statutory provision, agreement and evidence.

This scenario is illustrative, not a statement that any particular company has violated Australian law.

10. Practical compliance checklist

An organisation intending to undertake bioprospecting in Australia should verify the following before beginning work.

Pre-project compliance review

0 of 10

Identify the source, species and legal status of the biological resource.

Determine which Commonwealth, State or territory laws apply.

Obtain all required collection, access and protected-area permits.

Identify access providers, land rights and relevant native title interests.

Obtain required consent and negotiate benefit-sharing arrangements.

Address traditional knowledge, confidentiality and cultural restrictions.

Define sample ownership, intellectual property and downstream transfer rights.

Maintain collection records, audit trails and required research reports.

Verify export, biosecurity and overseas access-and-benefit-sharing requirements.

Review ongoing compliance when the research purpose or commercial use changes.

11. Conclusion

Bioprospecting licensing and enforcement in Australia rests on the interaction of environmental regulation, access permits, benefit-sharing agreements, Indigenous rights, contract law and intellectual property law.

The key legal principles are:

Lawful access comes first: the necessary authorisation depends on the location, resource and proposed research.

Commercial research requires additional scrutiny: benefit-sharing obligations may apply even when the initial collection is small.

Traditional knowledge requires separate consideration: lawful possession of a sample does not automatically authorise use of culturally sensitive knowledge.

Licensing and patents serve different purposes: patent rights do not retrospectively legalise unauthorised collection.

Enforcement is fact-specific: statutory penalties, injunctions, contractual remedies and other measures depend on the applicable legal framework.

For a real project, the most important first step is to identify the precise jurisdiction and the current legislation governing the collection site. The official Commonwealth access and permit guidance and Queensland biodiscovery framework are useful starting points.

Legal-information note: This is a general research overview, not legal advice. Current legislation, regulations, permit conditions and the specific facts of a proposed activity should be checked before collection or commercialisation.